Coronavirus cases Update: India reports less than 20,000 daily COVID-19 cases (18,795) after 201 days

COVID-19 cases in India: Uttar Pradesh, Delhi reported zero Covid deaths

India today reported less than 20,000 cases (18,795), for the first time since March 11. It is also a sharp drop from the cases reported yesterday (26,041). The country also reported 179 deaths, again a big dip from the 276 deaths reported a day ago.

Here are the top 10 updates on coronavirus in India:

The daily positivity rate - number of positive cases identified per 100 - stands at 1.42 per cent less than 3 per cent for last 29 days. The COVID-19 recovery rate stands at 97.81 per cent.
Less than 50,000 daily cases are being reported in the country for 93 consecutive days now, the union Ministry said.
Kerala, which continues to lead the states in daily Covid cases, saw a sharp drop with 11,699 cases in a day. The state also reported 58 deaths.
With 1,657 cases, Tamil Nadu is the second southern state after Kerala with a high daily caseload. It also reported 19 deaths.
Uttar Pradesh, the most populous state, reported six Covid cases, while neighbouring Delhi, the national capital, reported 32 cases. Both states reported zero Covid deaths.
Rajasthan, Gujarat, Madhya Pradesh, Bihar - the four big states - reported zero Covid deaths. Chhattisgarh, Jharkhand, Uttarakhand also reported zero Covid deaths.
With 1,846 cases, Mizoram leads the northeastern states in most number of new Covid cases in a day. The state also reported seven Covid deaths. It is followed by Assam, which reported 412 cases and eight Covid deaths.
The cumulative number of COVID-19 vaccine doses administered in the country crossed 86 crore, with over 1 crore doses given on Monday, the Union health ministry said. The daily COVID-19 vaccination in the country had crossed 1 crore for the first time on August 27.
The emergency use authorisation (EUA) for Covaxin, the Covid vaccine developed in India, has been further delayed as the World Health Organization (WHO) has sent more technical queries to its manufacturer Bharat Biotech, say sources. This delay is likely to adversely affect Indians', especially students', international travel plans. Without EUA, Covaxin will not be considered an accepted vaccine by most countries around the world.
Top medical body, Council of Scientific and Industrial Research (CSIR), has said that even if the third wave comes in the country, its intensity will be low.